Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3342220
Max Phase: Preclinical
Molecular Formula: C57H62N4O27S2
Molecular Weight: 1299.26
Molecule Type: Small molecule
Associated Items:
ID: ALA3342220
Max Phase: Preclinical
Molecular Formula: C57H62N4O27S2
Molecular Weight: 1299.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CC(=O)O[C@H]1C(=O)O[C@@H]2C[C@H]3C(C)=C(OC(=O)CCC(=O)OCCCCOc4no[n+]([O-])c4S(=O)(=O)c4ccccc4)C(=O)C[C@]3(C)[C@H]3[C@@H](O)[C@H](OC(=O)CCC(=O)OCCCCOc4no[n+]([O-])c4S(=O)(=O)c4ccccc4)[C@]4(C(=O)O)OC[C@]32[C@@H]14
Standard InChI: InChI=1S/C57H62N4O27S2/c1-31(2)27-42(67)85-45-47-56-30-82-57(47,54(70)71)48(86-41(66)22-20-39(64)79-24-12-14-26-81-50-52(61(73)88-59-50)90(76,77)34-17-9-6-10-18-34)43(68)46(56)55(4)29-36(62)44(32(3)35(55)28-37(56)83-53(45)69)84-40(65)21-19-38(63)78-23-11-13-25-80-49-51(60(72)87-58-49)89(74,75)33-15-7-5-8-16-33/h5-10,15-18,27,35,37,43,45-48,68H,11-14,19-26,28-30H2,1-4H3,(H,70,71)/t35-,37+,43+,45+,46+,47+,48-,55-,56+,57+/m0/s1
Standard InChI Key: COAJXUFYOBZQHN-DBTFCLFVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1299.26 | Molecular Weight (Monoisotopic): 1298.3043 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Tang W, Xie J, Xu S, Lv H, Lin M, Yuan S, Bai J, Hou Q, Yu S.. (2014) Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies., 57 (18): [PMID:25179783] [10.1021/jm5007534] |
Source(1):